Samsung Gets First U.S. Approval April 25, 2017By Christine BlankThe second Remicade biosimilar is only the fifth biosimilar approved in the United States. What You Need to Know About the NABP Annual MeetingThe 113th Annual Meeting will feature CPE, discussions, and more. Cherokee Nation Sues CVS, Walgreens, and Others Over Opioids April 25, 2017By Nicholas HammDid major chain pharmacies and distributors contribute to the opioid epidemic in Oklahoma? A Big Shift for a Major PBMAnthem is parting ways with Express Scripts. New NACDS Chairman Stresses Pro-Customer Leadership Role April 24, 2017By Anthony VecchioneNACDS’s Gourlay embraces leading the industry proactively through changing health-care industry. NACDS’ New Course April 24, 2017By Anthony VecchioneExpanded scope-of-practice/health-and-wellness figure prominently in new strategy. Pharmacists Joining the March for SciencePharmacists and pharmacy groups are taking part in a national march in support for science. Is $485 million enough to end the opioid epidemic? April 20, 2017By Christine BlankThe HHS is giving out greatly needed funds, but money alone may not be enough. FDA Issues New Label Change for Codeine and Tramadol April 20, 2017By Nicholas HammDecades of research has led to a flurry of new warnings.